AU4453299A - Polymorph of zopolrestat monohydrate - Google Patents
Polymorph of zopolrestat monohydrate Download PDFInfo
- Publication number
- AU4453299A AU4453299A AU44532/99A AU4453299A AU4453299A AU 4453299 A AU4453299 A AU 4453299A AU 44532/99 A AU44532/99 A AU 44532/99A AU 4453299 A AU4453299 A AU 4453299A AU 4453299 A AU4453299 A AU 4453299A
- Authority
- AU
- Australia
- Prior art keywords
- compound
- composition
- oxo
- dihydro
- methyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D519/00—Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/06—Antigout agents, e.g. antihyperuricemic or uricosuric agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Diabetes (AREA)
- Urology & Nephrology (AREA)
- Obesity (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Hematology (AREA)
- Vascular Medicine (AREA)
- Emergency Medicine (AREA)
- Endocrinology (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Physical Education & Sports Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Steroid Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Macromolecular Compounds Obtained By Forming Nitrogen-Containing Linkages In General (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US9747498P | 1998-08-21 | 1998-08-21 | |
| US60097474 | 1998-08-21 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AU4453299A true AU4453299A (en) | 2000-03-09 |
Family
ID=22263562
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU44532/99A Abandoned AU4453299A (en) | 1998-08-21 | 1999-08-17 | Polymorph of zopolrestat monohydrate |
Country Status (31)
| Country | Link |
|---|---|
| US (1) | US6159976A (es) |
| EP (1) | EP0982306A3 (es) |
| JP (1) | JP2000072769A (es) |
| KR (1) | KR20000017411A (es) |
| CN (1) | CN1245804A (es) |
| AP (1) | AP9901662A0 (es) |
| AU (1) | AU4453299A (es) |
| BG (1) | BG103674A (es) |
| BR (1) | BR9903873A (es) |
| CA (1) | CA2280590A1 (es) |
| EA (1) | EA199900675A3 (es) |
| EE (1) | EE9900385A (es) |
| GT (1) | GT199900137A (es) |
| HR (1) | HRP990259A2 (es) |
| HU (1) | HUP9902783A3 (es) |
| ID (1) | ID23307A (es) |
| IL (1) | IL131419A0 (es) |
| IS (1) | IS5155A (es) |
| MA (1) | MA26678A1 (es) |
| NO (1) | NO994027L (es) |
| NZ (1) | NZ337363A (es) |
| OA (1) | OA11150A (es) |
| PA (1) | PA8480601A1 (es) |
| PE (1) | PE20000993A1 (es) |
| PL (1) | PL335016A1 (es) |
| SG (1) | SG83147A1 (es) |
| TN (1) | TNSN99159A1 (es) |
| TR (1) | TR199901996A2 (es) |
| UY (1) | UY25668A1 (es) |
| YU (1) | YU39899A (es) |
| ZA (1) | ZA995297B (es) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105732640B (zh) | 2010-07-16 | 2019-01-08 | 纽约市哥伦比亚大学理事会 | 醛糖还原酶抑制剂及其用途 |
| US8916563B2 (en) | 2010-07-16 | 2014-12-23 | The Trustees Of Columbia University In The City Of New York | Aldose reductase inhibitors and uses thereof |
| WO2014126885A1 (en) * | 2013-02-13 | 2014-08-21 | Mylari Banavara L | Water soluble salts of aldose reductase inhibitors for treatment of diabetic complications |
| MX2018016122A (es) | 2016-06-21 | 2019-08-01 | Univ Columbia | Inhibidores de aldosa reductasa y metodos de uso. |
| CN111065392A (zh) | 2017-07-28 | 2020-04-24 | 应用治疗公司 | 用于治疗半乳糖血症的组合物和方法 |
| CA3132136A1 (en) | 2019-04-01 | 2020-10-08 | Andrew Wasmuth | Inhibitors of aldose reductase |
| EP4125909A1 (en) | 2020-03-31 | 2023-02-08 | Applied Therapeutics Inc. | Aldose reductase inhibitors for the treatment of acute respiratory distress syndrome, acute lung inflammation/injury, cardiac injury and anti-viral therapy |
| CA3176768A1 (en) | 2020-05-01 | 2021-11-04 | Shoshana SHENDELMAN | Aldose reductase inhibitors for treating sorbitol dehydrogenase deficiency |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4748280A (en) * | 1985-11-07 | 1988-05-31 | Pfizer Inc. | Certain chlorination process for preparing 2-chloro-1,1,1-(C1 -C6) |
| US4939140A (en) * | 1985-11-07 | 1990-07-03 | Pfizer Inc. | Heterocyclic oxophthalazinyl acetic acids |
| US4868301A (en) * | 1987-06-09 | 1989-09-19 | Pfizer Inc. | Processes and intermediates for the preparation of oxophthalazinyl acetic acids having benzothiazole or other heterocyclic side chains |
| JPH0676391B2 (ja) * | 1987-06-09 | 1994-09-28 | フアイザー・インコーポレイテツド | ベンゾチアゾール等の複素環側鎖を有するオキソフタラジニル酢酸類の製造方法 |
| US4904782A (en) * | 1988-02-29 | 1990-02-27 | Pfizer Inc. | Process for the production of phthalazineacetic acid ester derivatives and a novel intermediate |
| US4954629A (en) * | 1989-05-11 | 1990-09-04 | Pfizer Inc. | Process and intermediates for the preparation of oxophthalazinyl acetic acids and analogs thereof |
| WO1992003432A1 (en) * | 1990-08-28 | 1992-03-05 | Pfizer Inc. | 3-(5-trifluoromethylbenzothiazol-2-ylmethyl)-4-oxo-3h-phythalazin-1-ylacetic acid monohydrate |
| US5391551A (en) * | 1993-05-10 | 1995-02-21 | Pfizer Inc. | Method of lowering blood lipid levels |
| IL120264A0 (en) * | 1996-02-29 | 1997-06-10 | Pfizer | Method of reducing tissue damage associated with non-cardiac ischemia |
-
1999
- 1999-08-06 EP EP99306252A patent/EP0982306A3/en not_active Withdrawn
- 1999-08-13 US US09/374,729 patent/US6159976A/en not_active Expired - Fee Related
- 1999-08-16 IL IL13141999A patent/IL131419A0/xx unknown
- 1999-08-17 AU AU44532/99A patent/AU4453299A/en not_active Abandoned
- 1999-08-17 IS IS5155A patent/IS5155A/is unknown
- 1999-08-18 TN TNTNSN99159A patent/TNSN99159A1/fr unknown
- 1999-08-18 MA MA25738A patent/MA26678A1/fr unknown
- 1999-08-19 UY UY25668A patent/UY25668A1/es not_active Application Discontinuation
- 1999-08-19 GT GT199900137A patent/GT199900137A/es unknown
- 1999-08-19 YU YU39899A patent/YU39899A/sh unknown
- 1999-08-19 OA OA9900185A patent/OA11150A/en unknown
- 1999-08-19 ZA ZA9905297A patent/ZA995297B/xx unknown
- 1999-08-19 AP APAP/P/1999/001662A patent/AP9901662A0/en unknown
- 1999-08-19 SG SG9904131A patent/SG83147A1/en unknown
- 1999-08-19 EE EEP199900385A patent/EE9900385A/xx unknown
- 1999-08-19 HU HU9902783A patent/HUP9902783A3/hu unknown
- 1999-08-19 CA CA002280590A patent/CA2280590A1/en not_active Abandoned
- 1999-08-20 ID IDP990796A patent/ID23307A/id unknown
- 1999-08-20 NO NO994027A patent/NO994027L/no not_active Application Discontinuation
- 1999-08-20 BG BG103674A patent/BG103674A/xx unknown
- 1999-08-20 PL PL99335016A patent/PL335016A1/xx not_active Application Discontinuation
- 1999-08-20 EA EA199900675A patent/EA199900675A3/ru unknown
- 1999-08-20 KR KR1019990034527A patent/KR20000017411A/ko not_active Application Discontinuation
- 1999-08-20 BR BR9903873-0A patent/BR9903873A/pt not_active Application Discontinuation
- 1999-08-20 TR TR1999/01996A patent/TR199901996A2/xx unknown
- 1999-08-20 PE PE1999000844A patent/PE20000993A1/es not_active Application Discontinuation
- 1999-08-20 PA PA19998480601A patent/PA8480601A1/es unknown
- 1999-08-20 NZ NZ337363A patent/NZ337363A/xx unknown
- 1999-08-20 HR HR990259A patent/HRP990259A2/hr not_active Application Discontinuation
- 1999-08-23 JP JP11235855A patent/JP2000072769A/ja active Pending
- 1999-08-23 CN CN99118068A patent/CN1245804A/zh active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| PL335016A1 (en) | 2000-02-28 |
| OA11150A (en) | 2003-04-16 |
| TNSN99159A1 (fr) | 2005-11-10 |
| NZ337363A (en) | 2001-01-26 |
| EP0982306A2 (en) | 2000-03-01 |
| EP0982306A3 (en) | 2000-07-05 |
| YU39899A (sh) | 2002-12-10 |
| NO994027L (no) | 2000-02-22 |
| EE9900385A (et) | 2000-04-17 |
| AP9901662A0 (en) | 1999-09-30 |
| BR9903873A (pt) | 2000-09-19 |
| CA2280590A1 (en) | 2000-02-21 |
| IL131419A0 (en) | 2001-01-28 |
| ZA995297B (en) | 2001-02-19 |
| GT199900137A (es) | 2001-02-09 |
| EA199900675A2 (ru) | 2000-02-28 |
| EA199900675A3 (ru) | 2000-06-26 |
| US6159976A (en) | 2000-12-12 |
| NO994027D0 (no) | 1999-08-20 |
| PA8480601A1 (es) | 2000-09-29 |
| TR199901996A2 (xx) | 2000-03-21 |
| ID23307A (id) | 2000-04-05 |
| IS5155A (is) | 2000-02-22 |
| PE20000993A1 (es) | 2000-10-04 |
| HUP9902783A3 (en) | 2001-01-29 |
| JP2000072769A (ja) | 2000-03-07 |
| UY25668A1 (es) | 2001-08-27 |
| HRP990259A2 (en) | 2000-06-30 |
| CN1245804A (zh) | 2000-03-01 |
| SG83147A1 (en) | 2001-09-18 |
| HUP9902783A2 (hu) | 2000-12-28 |
| HU9902783D0 (en) | 1999-10-28 |
| MA26678A1 (fr) | 2004-12-20 |
| KR20000017411A (ko) | 2000-03-25 |
| BG103674A (en) | 2000-03-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN108516958B (zh) | 稠环衍生物、其制备方法、中间体、药物组合物及应用 | |
| US6054590A (en) | Imidazolone anorectic agents: II. phenyl derivatives | |
| KR20030048437A (ko) | 인돌린 유도체 및 5-ｈｔ2 수용체 리간드로서의 이들의 용도 | |
| WO1992000977A2 (en) | 4-alkylimidazole derivatives | |
| CN115304590B (zh) | 2h-苯并三氮唑衍生物及其制备方法及含有它们的药物组合物 | |
| EP1242418B1 (en) | Antidiabetic thiazolidinediones and their preparation | |
| US6159976A (en) | Polymorph of zopolrestat monohydrate | |
| SK47894A3 (en) | 2-amino-4-chinolyl-dihydropyridines, method of their production treatments containing thereof, method of their production, and using of these compounds | |
| CA2437402A1 (en) | New crystal forms of oxcarbazepine and processes for their preparation | |
| US6753334B2 (en) | Preparation of sodium-hydrogen exchanger type-1 inhibitors | |
| JPH0536436B2 (es) | ||
| KR101145433B1 (ko) | 로시글리타존 말레이트의 다형을 제조하는 방법 | |
| EP0738705B1 (en) | Gamma-diketone compound having platelet aggregation inhibiting effect | |
| MXPA99007842A (es) | Polimorfo de monohidrato de zopolrestat | |
| JP2002510283A (ja) | 抗糖尿病性、低脂質性及び抗高血圧性を有する置換チアゾリンジオンとオキサゾリジンジオン | |
| JPH05246994A (ja) | キノリルメトキシフエニル−アセトアミド類 | |
| JP2005320250A (ja) | ビスラクトン誘導体及びその医薬組成物としての使用 | |
| JPH02289555A (ja) | トリアジン誘導体 | |
| CZ9902918A3 (cs) | Polymorfy monohydrátu zopolrestatu, farmaceutické kompozice na jejich bázi a způsob jejich výroby | |
| MXPA04006937A (es) | Intermedios para la preparacion de inhibidores de la glucogeno fosforilasa. | |
| US20030119873A1 (en) | Methods for preparing sodium-hydrogen exchanger type-1 inhibitors | |
| JPH0451527B2 (es) | ||
| JPH0583554B2 (es) | ||
| JPH0673008A (ja) | アンジオテンシンｉｉ拮抗性ピリジン誘導体 | |
| AU2003256926A1 (en) | Substituted indolealkanoic acids derivative and formulations containing same for use in treatment of diabetic complications |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MK5 | Application lapsed section 142(2)(e) - patent request and compl. specification not accepted |